Navigation Links
Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
Date:1/30/2009

e and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to www.gen-probe.com.

About Non-GAAP Financial Measures

This announcement contains certain financial measures that are not calculated in accordance with U.S. GAAP, including non-GAAP EPS. Non-GAAP EPS excludes all non-cash charges such as intangible amortization and stock compensation expense, as well as transaction expenses. Gen-Probe's management believes these U.S. non-GAAP financial measures provide Gen-Probe investors meaningful supplemental information regarding the expected financial results of the acquisition.

Tepnel has not reconciled its historical financial statements to U.S. GAAP. All pro forma combined financial information in this press release is based upon a combination of Gen-Probe historical and projected financial information, prepared in accordance with U.S. GAAP, and Tepnel's historical and projected financial information, prepared in accordance with IFRS. Based on Gen-Probe's preliminary analysis, the Company does not anticipate material adjustments to reconcile U.S. GAAP with IFRS.

Caution Regarding Forward-Looking Statements

Any statements in this press release relating to Gen-Probe's offer and the Company's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made thr
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
2. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
3. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
4. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
5. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
6. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
7. Gen-Probe to Webcast Two Upcoming Investor Presentations
8. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
9. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
10. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
11. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 4 pm EDT): In a Viewpoint published today in ... a team of Boston researchers call for the implementation ... the United States. The researchers from the Friedman School ... University and Boston Children,s Hospital write that policies taxing ... both help people make meaningful dietary changes and substantially ...
(Date:9/2/2014)... Las Vegas, NV (PRWEB) September 02, 2014 ... a leading provider of “Cloud Based” Medical Practice Business ... and a provider of Digital Cyber Security solutions for ... was recently interviewed on the trading floor of the ... Flynn. Mr. DeLaGarza stated that we are very ...
(Date:9/2/2014)... by radiation therapy survived as long as patients ... study conducted by researchers at the Stanford University ... of California. , The comprehensive analysis of nearly ... first to directly compare survival rates following the ... removal of both breasts), unilateral mastectomy (the removal ...
(Date:9/2/2014)... 2014 Medex Analytic Services ... corporate headquarters in Coral Springs, Fla. due to their ... business development objectives for the 2014 year by distinguishing ... industry has requested a higher level of service and ... has delivered, and the industry has responded.” , The ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, Sept. ... as Adderall, Ritalin and Concerta -- used to treat ... a new study suggests. "Stimulant medication did not ... Dr. Slavica Katusic, an associate professor of pediatrics at ... that results of earlier studies have been mixed, with ...
Breaking Medicine News(10 mins):Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 4Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 2Health News:ADHD Medications Won't Stunt Kids' Growth, Study Finds 3
... , ... holidays. Overindulge, that is; on eggnog, cookies, candy and holiday buffet fare ... not to do the same with our four-legged, furry companions. The advent ... a healthier lifestyle for our pets, according to the experts at ...
... , WASHINGTON, Dec. 22 After taking ... Harry Reid and Senators Max Baucus (D-MT), Christopher Dodd (D-CT) ... bill, the Chairperson and President of the National Puerto Rican ... CEO Rafael A. Fantauzzi: , "We are on the ...
... between 2000 and 2005, a trend that could seriously impact ... if it continues, according to a study led by researchers ... Berkeley. The findings are troubling, said the authors, ... of disability rates among older adults may have ended. Adding ...
... cellulose produced by bacteria could be used for artificial blood ... of blood clots than the synthetic materials currently used for ... the University of Gothenburg, Sweden. Produced by a bacterium ... enough to cope with blood pressure and works well with ...
... suffering through a head cold knows, food tastes wrong when ... conclude that the sense of taste operates normally only when ... that the taste system influences olfactory perception, however, has been ... Nature Neuroscience , Brandeis researchers report just such an ...
... ... free treatment e-cards to the military and their families , ... Philadelphia (PRWEB) December 22, 2009 -- ... online holiday program advancing the company,s commitment to offer scientifically-based sound therapy downloads without ...
Cached Medicine News:Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 2Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 3Health News:Pets Resolve to 'Get Off On the Right Paw' in 2010 With a Healthy, Natural Diet and Exercise 4Health News:National Puerto Rican Coalition Urges Passage of Senate Health Bill 2Health News:Disability may be on the rise again after 20-year decline 2Health News:Disability may be on the rise again after 20-year decline 3Health News:Got taste? 2Health News:Prescription Audio Gives the Gift of Stress Relief This Holiday Season 2Health News:Prescription Audio Gives the Gift of Stress Relief This Holiday Season 3
(Date:9/2/2014)... Conn. , Sept. 2, 2014  Numotion is pleased ... the Company,s Board of Directors. Mark is ... number of leadership positions across the organization and was a ... Corporate Executive Council. Mark spent many years running business units ... CEO of GE Healthcare Americas. "We are ...
(Date:9/2/2014)... 2014 Reportlinker.com announces that a new ... Asia-Pacific Infusion Therapy Device Market ... Abstract: The Asia-Pacific ... infusion pumps, syringe infusion pumps, disposable infusion pumps, ... categories are segmented based on the type of ...
(Date:9/2/2014)... YORK , Sept. 2, 2014  Reportlinker.com announces ... its catalogue: Chinese and Taiwanese Markets ... http://www.reportlinker.com/p02353211/Chinese-and-Taiwanese-Markets-for-Minimally-Invasive-Spinal-Devices.html The market for ... and Emerging region is growing at a fast ... most striking growth is happening in China ...
Breaking Medicine Technology:Asia-Pacific Infusion Therapy Device Market 2Asia-Pacific Infusion Therapy Device Market 3Asia-Pacific Infusion Therapy Device Market 4Asia-Pacific Infusion Therapy Device Market 5Asia-Pacific Infusion Therapy Device Market 6Asia-Pacific Infusion Therapy Device Market 7Asia-Pacific Infusion Therapy Device Market 8Asia-Pacific Infusion Therapy Device Market 9Asia-Pacific Infusion Therapy Device Market 10Asia-Pacific Infusion Therapy Device Market 11Asia-Pacific Infusion Therapy Device Market 12Asia-Pacific Infusion Therapy Device Market 13Asia-Pacific Infusion Therapy Device Market 14Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9
... the Most Widely Prescribed Drug for Parkinson,s Disease, ... According to a New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical ... Parkinson,s,disease patients do not receive any drug treatment in ...
... Group Backs Construction of Facility, VIENNA, Va., Aug. ... that it has entered into an agreement with a,biomedical ... use of,a dedicated manufacturing facility for its cancer drug ... about $15 million. This,facility is located near Baltimore, Maryland. ...
Cached Medicine Technology:Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis 2Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 2CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 4
... Endotracheal Tube Kits (silicone) Magill, ... includes a SidePort™ AutoControl™ airway connector, ... mm ISO connector., ,The wire ... helping to ensure an open airway., ...
... Portex® Blue Line® uncuffed endotracheal ... or Murphy styles, in standard ... Line® adult and pediatric uncuffed ... implant-tested polyvinyl chloride with a ...
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
... Rusch Safety Clear Plus™ Uncuffed Endotracheal Tube w. ... Sterile, Single use. A quality Rusch endotracheal tube ... use saving you time and storage space. The ... smooth withdrawal. It is designed with a soft ...
Medicine Products: